161 related articles for article (PubMed ID: 29929667)
1. Harmful Effects of Exercise Intensity and Exercise Duration in Patients With Arrhythmogenic Cardiomyopathy.
Lie ØH; Dejgaard LA; Saberniak J; Rootwelt C; Stokke MK; Edvardsen T; Haugaa KH
JACC Clin Electrophysiol; 2018 Jun; 4(6):744-753. PubMed ID: 29929667
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Life-Threatening Ventricular Arrhythmia in Patients With Arrhythmogenic Cardiomyopathy: A Primary Prevention Cohort Study.
Lie ØH; Rootwelt-Norberg C; Dejgaard LA; Leren IS; Stokke MK; Edvardsen T; Haugaa KH
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1377-1386. PubMed ID: 30031702
[TBL] [Abstract][Full Text] [Related]
3. Life-threatening arrhythmic presentation in patients with arrhythmogenic cardiomyopathy before and after entering the genomic era; a two-decade experience from a large volume center.
Rootwelt-Norberg C; Lie ØH; Dejgaard LA; Chivulescu M; Leren IS; Edvardsen T; Haugaa KH
Int J Cardiol; 2019 Mar; 279():79-83. PubMed ID: 30638987
[TBL] [Abstract][Full Text] [Related]
4. Left Ventricular Dysfunction in Arrhythmogenic Cardiomyopathy: Association With Exercise Exposure, Genetic Basis, and Prognosis.
Lie ØH; Chivulescu M; Rootwelt-Norberg C; Ribe M; Bogsrud MP; Lyseggen E; Beitnes JO; Almaas V; Haugaa KH
J Am Heart Assoc; 2021 Apr; 10(8):e018680. PubMed ID: 33821670
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in disease progression and arrhythmic risk in patients with arrhythmogenic cardiomyopathy.
Rootwelt-Norberg C; Lie ØH; Chivulescu M; Castrini AI; Sarvari SI; Lyseggen E; Almaas VM; Bogsrud MP; Edvardsen T; Haugaa KH
Europace; 2021 Jul; 23(7):1084-1091. PubMed ID: 33829244
[TBL] [Abstract][Full Text] [Related]
6. Right Ventricular Functional Abnormalities in Arrhythmogenic Cardiomyopathy: Association With Life-Threatening Ventricular Arrhythmias.
Kirkels FP; Lie ØH; Cramer MJ; Chivulescu M; Rootwelt-Norberg C; Asselbergs FW; Teske AJ; Haugaa KH
JACC Cardiovasc Imaging; 2021 May; 14(5):900-910. PubMed ID: 33582062
[TBL] [Abstract][Full Text] [Related]
7. Impact of Exercise Restriction on Arrhythmic Risk Among Patients With Arrhythmogenic Right Ventricular Cardiomyopathy.
Wang W; Orgeron G; Tichnell C; Murray B; Crosson J; Monfredi O; Cadrin-Tourigny J; Tandri H; Calkins H; James CA
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909402
[TBL] [Abstract][Full Text] [Related]
8. Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers.
Sawant AC; Te Riele AS; Tichnell C; Murray B; Bhonsale A; Tandri H; Judge DP; Calkins H; James CA
Heart Rhythm; 2016 Jan; 13(1):199-207. PubMed ID: 26321091
[TBL] [Abstract][Full Text] [Related]
9. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Without an Implantable Cardioverter-Defibrillator.
Maupain C; Badenco N; Pousset F; Waintraub X; Duthoit G; Chastre T; Himbert C; Hébert JL; Frank R; Hidden-Lucet F; Gandjbakhch E
JACC Clin Electrophysiol; 2018 Jun; 4(6):757-768. PubMed ID: 29929669
[TBL] [Abstract][Full Text] [Related]
10. Left Ventricular Involvement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Assessed by Echocardiography Predicts Adverse Clinical Outcome.
Mast TP; Teske AJ; vd Heijden JF; Groeneweg JA; Te Riele AS; Velthuis BK; Hauer RN; Doevendans PA; Cramer MJ
J Am Soc Echocardiogr; 2015 Sep; 28(9):1103-13.e9. PubMed ID: 26025724
[TBL] [Abstract][Full Text] [Related]
11. Performance of the 2015 International Task Force Consensus Statement Risk Stratification Algorithm for Implantable Cardioverter-Defibrillator Placement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
Orgeron GM; Te Riele A; Tichnell C; Wang W; Murray B; Bhonsale A; Judge DP; Kamel IR; Zimmerman SL; Tandri H; Calkins H; James CA
Circ Arrhythm Electrophysiol; 2018 Feb; 11(2):e005593. PubMed ID: 29453325
[TBL] [Abstract][Full Text] [Related]
12. Implantable Cardioverter-Defibrillator Therapy in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Predictors of Appropriate Therapy, Outcomes, and Complications.
Orgeron GM; James CA; Te Riele A; Tichnell C; Murray B; Bhonsale A; Kamel IR; Zimmerman SL; Judge DP; Crosson J; Tandri H; Calkins H
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28588093
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
[TBL] [Abstract][Full Text] [Related]
14. Number of pregnancies and subsequent phenotype in a cross-sectional cohort of women with arrhythmogenic cardiomyopathy.
Castrini AI; Lie ØH; Leren IS; Estensen ME; Stokke MK; Klæboe LG; Edvardsen T; Haugaa KH
Eur Heart J Cardiovasc Imaging; 2019 Feb; 20(2):192-198. PubMed ID: 29659777
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.
Corrado D; Calkins H; Link MS; Leoni L; Favale S; Bevilacqua M; Basso C; Ward D; Boriani G; Ricci R; Piccini JP; Dalal D; Santini M; Buja G; Iliceto S; Estes NA; Wichter T; McKenna WJ; Thiene G; Marcus FI
Circulation; 2010 Sep; 122(12):1144-52. PubMed ID: 20823389
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
[TBL] [Abstract][Full Text] [Related]
17. Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Saguner AM; Vecchiati A; Baldinger SH; Rüeger S; Medeiros-Domingo A; Mueller-Burri AS; Haegeli LM; Biaggi P; Manka R; Lüscher TF; Fontaine G; Delacrétaz E; Jenni R; Held L; Brunckhorst C; Duru F; Tanner FC
Circ Cardiovasc Imaging; 2014 Mar; 7(2):230-9. PubMed ID: 24515411
[TBL] [Abstract][Full Text] [Related]
18. Lifelong arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy: distribution of events and impact of periodical reassessment.
Cappelletto C; Stolfo D; De Luca A; Pinamonti B; Barbati G; Pivetta A; Gobbo M; Brun F; Merlo M; Sinagra G
Europace; 2018 Jun; 20(FI1):f20-f29. PubMed ID: 28633348
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
Mazzanti A; Ng K; Faragli A; Maragna R; Chiodaroli E; Orphanou N; Monteforte N; Memmi M; Gambelli P; Novelli V; Bloise R; Catalano O; Moro G; Tibollo V; Morini M; Bellazzi R; Napolitano C; Bagnardi V; Priori SG
J Am Coll Cardiol; 2016 Dec; 68(23):2540-2550. PubMed ID: 27931611
[TBL] [Abstract][Full Text] [Related]
20. Arrhythmogenic Right Ventricular Cardiomyopathy Caused by a Novel Frameshift Mutation.
Refaat MM; Tang P; Harfouch N; Wojciak J; Kwok PY; Scheinman M
Card Electrophysiol Clin; 2016 Mar; 8(1):217-21. PubMed ID: 26920198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
